These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 14550427

  • 1. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.
    Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, Steinhoff G, Brock G, Patrick AB, Flax S, Goldfarb B, Palmer BW, Zadra J.
    Urology; 2003 Oct; 62(4):614-7. PubMed ID: 14550427
    [Abstract] [Full Text] [Related]

  • 2. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ.
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [Abstract] [Full Text] [Related]

  • 3. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial.
    Nickel JC, Johnston B, Downey J, Barkin J, Pommerville P, Gregoire M, Ramsey E.
    Urology; 2000 Sep 01; 56(3):413-7. PubMed ID: 10962305
    [Abstract] [Full Text] [Related]

  • 4. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.
    Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, Pontari MA, McNaughton-Collins M, Shoskes DA, Comiter CV, Datta NS, Fowler JE, Nadler RB, Zeitlin SI, Knauss JS, Wang Y, Kusek JW, Nyberg LM, Litwin MS, Chronic Prostatitis Collaborative Research Network.
    Ann Intern Med; 2004 Oct 19; 141(8):581-9. PubMed ID: 15492337
    [Abstract] [Full Text] [Related]

  • 5. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial.
    Nickel JC, Downey J, Johnston B, Clark J, Canadian Prostatitis Research Group.
    J Urol; 2001 May 19; 165(5):1539-44. PubMed ID: 11342913
    [Abstract] [Full Text] [Related]

  • 6. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC, Narayan P, McKay J, Doyle C.
    J Urol; 2004 Apr 19; 171(4):1594-7. PubMed ID: 15017228
    [Abstract] [Full Text] [Related]

  • 7. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
    Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J, Rofecoxib Prostatitis Investigator Team.
    J Urol; 2003 Apr 19; 169(4):1401-5. PubMed ID: 12629372
    [Abstract] [Full Text] [Related]

  • 8. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D, Wang P, Chen J, Wang S, Jiang H.
    Chin Med J (Engl); 2011 Jul 19; 124(14):2158-61. PubMed ID: 21933619
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Zhang K, Liu Y, Yang W, Wang J, Yang J, Zhang G, Bai W, Chen S.
    Urology; 2021 Jul 19; 153():264-269. PubMed ID: 33482135
    [Abstract] [Full Text] [Related]

  • 10. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study.
    Falahatkar S, Shahab E, Gholamjani Moghaddam K, Kazemnezhad E.
    BJU Int; 2015 Oct 19; 116(4):641-9. PubMed ID: 25307409
    [Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
    Wang J, Yan D, Liang K, Xu Z.
    Int Urol Nephrol; 2016 Jan 19; 48(1):13-8. PubMed ID: 26577998
    [Abstract] [Full Text] [Related]

  • 12. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study.
    Nickel JC, Forrest JB, Tomera K, Hernandez-Graulau J, Moon TD, Schaeffer AJ, Krieger JN, Zeitlin SI, Evans RJ, Lama DJ, Neal DE, Sant GR.
    J Urol; 2005 Apr 19; 173(4):1252-5. PubMed ID: 15758763
    [Abstract] [Full Text] [Related]

  • 13. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H, Koie T, Soma O, Matsumoto T, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C.
    BMC Urol; 2015 Dec 07; 15():120. PubMed ID: 26643109
    [Abstract] [Full Text] [Related]

  • 14. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
    Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI.
    BJU Int; 2004 May 07; 93(7):991-5. PubMed ID: 15142149
    [Abstract] [Full Text] [Related]

  • 15. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial.
    Pontari MA, Krieger JN, Litwin MS, White PC, Anderson RU, McNaughton-Collins M, Nickel JC, Shoskes DA, Alexander RB, O'Leary M, Zeitlin S, Chuai S, Landis JR, Cen L, Propert KJ, Kusek JW, Nyberg LM, Schaeffer AJ, Chronic Prostatitis Collaborative Research Network-2.
    Arch Intern Med; 2010 Sep 27; 170(17):1586-93. PubMed ID: 20876412
    [Abstract] [Full Text] [Related]

  • 16. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC.
    BJU Int; 2012 Oct 27; 110(7):1014-22. PubMed ID: 22471591
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
    Paglia M, Peterson J, Fisher AC, Qin Z, Nicholson SC, Kahn JB.
    Curr Med Res Opin; 2010 Jun 27; 26(6):1433-41. PubMed ID: 20394471
    [Abstract] [Full Text] [Related]

  • 18. Effect of Essential Oil on Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Randomized Controlled Trial.
    Ying J, Zhou MJ, Chen HY, Chen L, Zhang W, Ji J, Yu C, Zhang ZJ.
    Chin J Integr Med; 2019 Feb 27; 25(2):91-95. PubMed ID: 29948596
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial.
    Choe HS, Lee SJ, Han CH, Shim BS, Cho YH.
    J Infect Chemother; 2014 Jan 27; 20(1):20-5. PubMed ID: 24462419
    [Abstract] [Full Text] [Related]

  • 20. Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study.
    Wagenlehner FM, Ballarini S, Naber KG.
    World J Urol; 2014 Dec 27; 32(6):1595-603. PubMed ID: 24482313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.